A fully human monoclonal antibody to the insulin-like growth factor I receptor blocks ligand-dependent signaling and inhibits human tumor growth in vivo.
Data up to Jan 2025
Total Citations Per Year
Abstract
References (52)
Antiapoptotic Signalling by the Insulin-Like Growth Factor I Receptor, Phosphatidylinositol 3-Kinase, and Akt
1997 • 1,051 citations
Insulin-Like Growth Factor-I Receptor Signaling and Resistance to Trastuzumab (Herceptin)
2001 • 868 citations
Structure and function of the type 1 insulin-like growth factor receptor
2000 • 602 citations
A Large Non-immunized Human Fab Fragment Phage Library That Permits Rapid Isolation and Kinetic Analysis of High Affinity Antibodies
1999 • 527 citations
Circulating insulin-like growth factor-I levels regulate colon cancer growth and metastasis.
2002 • 374 citations
Expression of the type 1 insulin-like growth factor receptor is up-regulated in primary prostate cancer and commonly persists in metastatic disease.
2002 • 371 citations
Insulin-like growth factor-I receptor overexpression mediates cellular radioresistance and local breast cancer recurrence after lumpectomy and radiation.
1997 • 343 citations
Blockade of the type I somatomedin receptor inhibits growth of human breast cancer cells in athymic mice.
1989 • 334 citations
Insulin-like growth factor receptor expression and function in human breast cancer.
1990 • 321 citations
Insulin-like growth factor physiology and cancer risk
2000 • 299 citations
Insulin and insulin-like growth factor-I (IGF-I) receptor overexpression in breast cancers leads to insulin/IGF-I hybrid receptor overexpression: evidence for a second mechanism of IGF-I signaling.
1999 • 254 citations
Role of tyrosine kinase activity in signal transduction by the insulin-like growth factor-I (IGF-I) receptor. Characterization of kinase-deficient IGF-I receptors and the action of an IGF-I-mimetic antibody (alpha IR-3).
1993 • 247 citations
The contradictions of the insulin-like growth factor 1 receptor
2000 • 236 citations
Growth inhibition of human breast cancer cells in vitro with an antibody against the type I somatomedin receptor.
1989 • 233 citations
In vivo progression of LAPC-9 and LNCaP prostate cancer models to androgen independence is associated with increased expression of insulin-like growth factor I (IGF-I) and IGF-I receptor (IGF-IR).
2001 • 230 citations
Dominant negative inhibition of tumorigenesis in vivo by human insulin-like growth factor I receptor mutant.
1994 • 195 citations
Insulin‐like growth factor (IGF)‐I rescues breast cancer cells from chemotherapy‐induced cell death – proliferative and anti‐apoptotic effects
1999 • 192 citations
A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.
2003 • 189 citations
In vivo treatment with antibody against IGF-1 receptor suppresses growth of human rhabdomyosarcoma and down-regulates p34cdc2.
1994 • 186 citations
Inhibition of cellular proliferation by peptide analogues of insulin-like growth factor 1.
1992 • 183 citations
A soluble insulin-like growth factor I receptor that induces apoptosis of tumor cells in vivo and inhibits tumorigenesis.
1996 • 181 citations
Blockage of insulin-like growth factor-I receptor inhibits the growth of Ewing's sarcoma in athymic mice.
1998 • 181 citations
Insulin-like Growth Factor Expression in Human Cancer Cell Lines
1996 • 179 citations
Insulin-like growth factor-1 receptor in uveal melanoma: a predictor for metastatic disease and a potential therapeutic target.
2002 • 177 citations
Insulin-like growth factor I is a dual effector of multiple myeloma cell growth
2000 • 171 citations
Inhibition of human leukemia in an animal model with human antibodies directed against vascular endothelial growth factor receptor 2. Correlation between antibody affinity and biological activity
2003 • 160 citations
Specificity in ligand binding and intracellular signalling by insulin and insulin-like growth factor receptors
2001 • 157 citations
Human antibodies by design
1998 • 157 citations
Inhibition of insulin-like growth factor I receptor increases the antitumor activity of doxorubicin and vincristine against Ewing's sarcoma cells.
2001 • 141 citations
Selection of high affinity human neutralizing antibodies to VEGFR2 from a large antibody phage display library for antiangiogenesis therapy
2001 • 137 citations
Epidermal Growth Factor Receptor as a Therapeutic Target in Colorectal Cancer
2003 • 121 citations
Type 1 IGF receptor in human breast diseases
1992 • 120 citations
Growth Factor Receptors in Breast Cancer: Potential for Therapeutic Intervention
2003 • 116 citations
Expression of insulin-like growth factor I, its binding proteins, and its receptor in ovarian cancer.
1991 • 115 citations
Expression of an IGF‐I receptor dominant negative mutant induces apoptosis, inhibits tumorigenesis and enhances chemosensitivity in Ewing's sarcoma cells
2002 • 111 citations
Insulin-like growth factor II binding to the type I somatomedin receptor. Evidence for two high affinity binding sites.
1986 • 104 citations
The IGF system : molecular biology, physiology, and clinical applications
1999 • 99 citations
Insulin-like growth factors and breast cancer
1995 • 96 citations
Insulin-like Growth Factor-I (IGF-I) Receptor Activation Rescues UV-damaged Cells through a p38 Signaling Pathway
2001 • 92 citations
Neutralizing anti-insulin-like growth factor receptor 1 antibodies inhibit receptor function and induce receptor degradation in tumor cells.
2002 • 92 citations
TCR-Like Human Antibodies Expressed on Human CTLs Mediate Antibody Affinity-Dependent Cytolytic Activity
2002 • 75 citations
Insulin-like Growth Factor I Receptor Antagonism Augments Response to Chemoradiation Therapy in Colon Cancer Cells
2000 • 69 citations
Varying patterns of expression of insulin-like growth factors I and II and their receptors in murine mammary adenocarcinomas of different metastasizing ability
1996 • 49 citations
JB3, an IGF-I Receptor Antagonist, Inhibits Early Renal Growth in Diabetic and Uninephrectomized Rats
2000 • 48 citations
High-affinity insulin binding to an atypical insulin-like growth factor-I receptor in human breast cancer cells.
1992 • 45 citations
The insulin-like growth factor system as a therapeutic target in colorectal cancer
2002 • 42 citations
Characterization of Ligand Binding of a Soluble Human Insulin-like Growth Factor I Receptor Variant Suggests a Ligand-induced Conformational Change
1997 • 40 citations
Effects of insulin-like growth factor receptor inhibition on human melanomas in culture and in athymic mice.
1993 • 39 citations
Antisense phosphorothioate oligodeoxynucleotide down-regulation of the insulin-like growth factor I receptor in ovarian cancer cells
1998 • 34 citations
IGF-I Receptor Function
1999 • 31 citations
Relaxation of Insulin-Like Growth Factor-ll Gene Imprinting in Human Gynecologic Tumors
1997 • 20 citations
Monoclonal antibody therapy
2001 • 16 citations
Cited By (0)
No citing papers found in database